GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly becoming a prominent focus in healthcare investigation, largely due to its notable impact on controlling conditions such as type 2 diabetes and weight gain. Recent trials have revealed that more than glucose regulation, GLP-1 agonists offer benefits for heart health and perha… Read More